| abstract |
This invention provides compounds of Formula I having the structurewhereinA, Q, R3, and R4 are as defined hereinbefore in the specification,or a pharmaceutically acceptable salt thereof, which are useful in treating metabolic disorders related to insulin resistance or hyperglycemia. |